News

Stille AB holds its annual general meeting on May 7, 2026, at 14:00 CEST, at Advokatfirman Lindahl’s offices on Smålandsgatan 16, Stockholm, Sweden. Registration starts at 13:30 CEST. REQUIREMENTS FOR PARTICIPATION Shareholders wishing to attend the meeting shall: Notification of attendance may be made in writing to the company on the address Stille AB, Att: Annual general meeting 2026...

Today, Stille AB publishes the annual report for 2025. The report can be found on the company website www.stille.se. A full translated version in English will be provided on Stille’s website latest April 29th. Torshälla, April 2nd, 2026. Contact DetailsUlrik BerthelsenCEO & President+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se About UsStille AB (publ) is a well-established pioneer...

Net sales amounted to MSEK 174.9 (161.2), an increase of 8.5 percent (negative organic growth of 6.1 percent). The quarter was negatively impacted by the phase-out of non-strategic products in surgical instruments that began in early 2025 (MSEK 5.8) and a negative currency effect (MSEK 9.9). Adjusted for these two factors, underlying organic growth would have amounted to 3.7 percent. ” The supply...

The previous press release was issued at 14:00 CET and has been updated to correct a typo. No other changes have been made to the original release. The nominating committee in Stille AB (publ) (“Stille”, or “the Company”) shall consist of three members, who shall represent the three shareholders with the highest number of shares willing to participate in the nominating committee...

The nominating committee in Stille AB (publ) (“Stille”, or “the Company”) shall consist of three members, who shall represent the three shareholders with the highest number of shares willing to participate in the nominating committee, along with the Chairman of the Board. The nominating committee shall be appointed during the fourth quarter based on the shareholding at the end...

Revenue amounted to 138.8 MSEK (127.9), an increase of 8.5 percent, of which a negative organic growth of 1.9 percent. The quarter was negatively impacted by the phase-out of non-strategic products in surgical instruments that began in early 2025 and a negative currency effect. Adjusted for these two factors, underlying organic growth would have amounted to 7.3 percent. “We had a continued strong...

Stille AB (publ) announces new Executive Management team, with the appointment of Niklas Tyrén as Group CFO and Martin Richardson as Group COO. Stille AB today announces a new Executive Management and group structure to support the company’s continued international growth. The new organization strengthens group capabilities in Finance, Operations and QA/RA. We are announcing the appointment...

Stille AB (publ) informs that Johan Lundholm has decided to leave his position as Business Unit Manager for Surgical Tables of Stille to pursue a new opportunity outside the company. "I would like to thank Johan for his contributions over the past four years and wish him all the best in his future endeavors. He has played an important role in driving the commercial development of the surgical...

Stille AB (publ) (“Stille”) today confirms that the previously announced acquisition of Surgical Holdings Ltd (“Surgical Holdings”) has been completed. All closing conditions have been satisfied, and the shares have now been transferred to Stille. As previously communicated, the total consideration of c. GBP 7.7 million (corresponding to c. SEK 99.4 million) on a cash and debt-free...

Stille AB (publ) today presents the report for the second quarter 2025. Revenue amounted to 124.7 MSEK (142.6). Order intake remained strong but was impacted by continued supply-chain constraints, the phase-out of non-strategic products, and currency headwinds. “Order intake remained strong and largely in line with our growth targets, providing a solid foundation for recovery,” says Ulrik...